GMP grade Palmitoylethanolamide – OptiPEA®
Nijmegen, The Netherlands – Innexus Nutraceuticals announced the worldwide launch of OptiPEA® (www.optipea.com), EU GMP grade palmitoylethanolamide. Safety, quality and reliability are rising standards for nutraceutical ingredients and customers should not expect less. That is why dietary supplement companies are relying more and more on branded ingredients for their products.
“We have redefined PEA as an ingredient by producing in accordance with the high GMP production standards used in the pharmaceutical industry” says Samuel Zonneveld, CEO, Innexus Nutraceuticals.
The problem with currently used PEA
Whether a brand name implies quality, purity or superiority, most, if not all of the PEA commonly used in dietary supplement products, will be obtained from the Asian chemical industry. “I would not recommend to use any PEA products of which the quality and manufacturing data are unclear or not traceable”.
PEA is a nutraceutical that controls physiological mechanisms associated with chronic pain. It functions with more than one “modus operandi”. This “shot gun” effect is essential to making this molecule so effective for tackling the complexity of chronic pain.
OptiPEA® is now available as a bulk powder or as bulk capsules for companies that are looking to expand their product line. In Q1 of 2016 the first consumer products with OptiPEA® will be available in Europe. It is expected that the launch will have a big impact as the concerning issues with safety and quality are now resolved.
About Innexus Nutraceuticals
Innexus Nutraceuticals is a manufacturer of specialty nutraceuticals. They work with talented PhD chemists and experts in the nutritional field to develop and market exciting ingredients. We strive to produce the highest quality and make no concessions with regard to safety. Innexus Nutraceutical is headquartered in Nijmegen, The Netherlands. For more information see: www.innexusnutraceuticals.com.
Innexus Nutraceuticals B.V.
+31 (0)85 3034209 | email@example.com